PARP 1 Inhibitor
Interviews and expert commentary tagged “PARP 1 Inhibitor” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Oncology
Timothy Yap MD PhD MBBS: Selective PARP1 Inhibitor Saruparib Clinical Promise in Solid Tumors with Homologous Recombination Repair Deficiency
Timothy Yap MD PhD MBBS selective PARP inhibitor promise in breast, ovarian, pancreatic, prostate tumors.
22 September 2025
18:45